Blood test could replace painful spinal tap for Alzheimer's diagnosis

NCT ID NCT07071649

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether a blood test measuring a protein called p-Tau217 can diagnose Alzheimer's disease as accurately as the current method, which requires a spinal tap. Researchers will compare results from blood and spinal fluid samples from 40 adults with suspected Alzheimer's. If successful, this could lead to a simpler, less invasive way to diagnose the disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHRU Amiens

    RECRUITING

    Amiens, 80090, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.